# US 2026/0271867 A1 · New sporeless pleurotus strain

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2026/0271867 A1
- Document ID: US20260271867A1
- Status: Published application
- Kind: A1
- Application number: 19/168,138
- Filed: 2024-03-28
- Published: 2026-09-17
- Earliest claimed: 2023-03-28
- Assignees: Somycel
- Applicants: Somycel
- Inventors: Aniça AMINI; Ségolène PÉGÉ; Mark WACH
- Web page: https://patentgrep.com/patent/US20260271867A1

## CPC

- A01H 15/00: Fungi; Lichens (fungal microorganisms C12N1/14)
- A01G 18/50: Inoculation of spawn
- A01H 1/021: {Methods of breeding using interspecific crosses, i.e. interspecies crosses}
- A01H: NEW PLANTS OR {NON-TRANSGENIC} PROCESSES FOR OBTAINING THEM; PLANT REPRODUCTION BY TISSUE CULTURE TECHNIQUES
- A01G: HORTICULTURE; CULTIVATION OF VEGETABLES, FLOWERS, RICE, FRUIT, VINES, HOPS OR SEAWEED; FORESTRY; WATERING (picking of fruits, vegetables, hops or the like A01D46/00; propagating unicellular algae C12N1/12)

## Abstract

The present invention relates to the development of a new sporeless Pleurotus strain designated FiBABH-334, a representative culture thereof having been deposited at the Collection Nationale de Cultures de Microorganismes (CNCM), Institut Pasteur, 25 rue du Docteur Roux, 75724 PARIS Cedex 15, on Mar. 21, 2023, under the CNCM Accession Number I-5939. This sporeless Pleurotus strain displays an excellent yield weight of the harvested crop and a very good shelf-life of the mushroom products. The present invention also relates to cultures obtained, descended, or otherwise derived from this strain. More particularly, the present invention relates to cultures comprising at least one haploid set of chromosomes of said strain, especially to monokaryons thereof or to F1 hybrids produced by mating this monokaryon with a second Pleurotus line. The invention further relates to methods of use of the cultures described hereinabove.

## Claims

### Claim 1

A sporeless Pleurotus strain comprising at least one haploid set of chromosomes of the strain FiBABH-334, a representative culture of said strain having been deposited under the CNCM Accession Number 1-5939 at the Collection Nationale de Cultures de Microorganismes (CNCM), Institut Pasteur, 25 rue du Docteur Roux, 75724 PARIS Cedex 15, on Mar. 21, 2023.

### Claim 2 (depends on 1)

The sporeless Pleurotus strain of claim 1, characterized in that it is selected from the group consisting of:
(a) F1 hybrids produced by mating a monokaryon from FiBABH-334 with a second line;
(b) the strain FiBABH-334, a representative culture of said strain having been deposited under the CNCM Accession Number 1-5939 at the Collection Nationale de Cultures de Microorganismes (CNCM), Institut Pasteur, 25 rue du Docteur Roux, 75724 PARIS Cedex 15, on Mar. 21, 2023;
(c) derivatives of the strain (b), said derivatives being cells obtained from said FIBABH-334 strain by somatic selection, tissue culture selection, single spore germination, multiple spore germination, matings between mycelium obtained from monokaryotic or dikaryotic spores from these hybrids, selfing, repeated mating back to the initial culture, mutagenesis, trait conversion, introgressive trait conversion, inbreeding or transformation; and
(d) a monokaryon of the strain FiBABH-334, a representative culture of said strain having been deposited under the CNCM Accession Number 1-5939 at the Collection Nationale de Cultures de Microorganismes (CNCM), Institut Pasteur, 25 rue du Docteur Roux, 75724 PARIS Cedex 15, on Mar. 21, 2023.

### Claim 3 (depends on 2)

The sporeless Pleurotus strain of claim 2, which is a derivative of the strain as defined in claim 2(b), said derivatives being cells obtained from said FiBABH-334 strain by somatic selection, tissue culture selection, single spore germination, multiple spore germination, matings between mycelium obtained from monokaryotic or dikaryotic spores from these hybrids, selfing, repeated mating back to the initial culture, mutagenesis, trait conversion, introgressive trait conversion, inbreeding or transformation;
comprising at least 99%, or at least 98%, or at least 95%, or at least 92%, or at least 90%, or at least 85%, or at least 80%, or at least 75%, or at least 70%, or at least 65%, or at least 60%, or at least 55%, or at least 50%, or at least 45%, or at least 40%, or at least 30%, or at least 20%, or at least 10%, of the sequence-characterized allelic markers of FiBABH-334 listed in Table A.

### Claim 4 (depends on 2)

The sporeless Pleurotus strain of claim 2, which is a derivative of the strain as defined in claim 2(b), said derivatives being cells obtained from said FiBABH-334 strain by somatic selection, tissue culture selection, single spore germination, multiple spore germination, matings between mycelium obtained from monokaryotic or dikaryotic spores from these hybrids, selfing, repeated mating back to the initial culture, mutagenesis, trait conversion, introgressive trait conversion, inbreeding or transformation;
comprising between 80%-100%, or between 60-80%, or between 40-60%, or between 20-40% of the sequence-characterized allelic markers of FIBABH-334 listed in Table A.

### Claim 5

A sporeless Pleurotus strain of the F2 or F3 generation, descended from the strain FiBABH-334, or from a strain derived from strain FIBABH-334, a representative culture of said line having been deposited at the Collection Nationale de Cultures de Microorganismes (CNCM), Institut Pasteur, 25 rue du Docteur Roux, 75724 PARIS Cedex 15, on Mar. 21, 2023, under the CNCM Accession Number 1-5939; or a sporeless Pleurotus mushroom strain that is derived from the initial strain FiBABH-334, a representative culture of said strain having been deposited under the CNCM Accession Number 1-5939 at the Collection Nationale de Cultures de Microorganismes (CNCM), Institut Pasteur, 25 rue du Docteur Roux, 75724 PARIS Cedex 15, on Mar. 21, 2023.

### Claim 6 (depends on 5)

The sporeless Pleurotus strain of claim 5, which is a sporeless Pleurotus strain of the F2 or F3 generation descending from FiBABH-334 or from a strain derived from FiBABH-334, comprising at least about 200 allelic markers out of the 298 sequence-characterized allelic markers of FiBABH-334 listed in Table A.

### Claim 7 (depends on 5)

The sporeless Pleurotus strain of claim 5, which is a sporeless Pleurotus strain of the F2 or F3 generation descending from FiBABH-334 or from a strain derived from FiBABH-334, comprising at least 99%, or at least 98%, or at least 95%, or at least 92%, or at least 90%, or at least 85%, or at least 80%, or at least 75%, or at least 70%, or at least 65%, or at least 60%, or at least 55%, or at least 50%, or at least 45%, or at least 40%, or at least 30%, or at least 20%, or at least 10%, of the sequence-characterized allelic markers of FIBABH-334 listed in Table A.

### Claim 8 (depends on 5)

The sporeless Pleurotus strain of claim 5, which is a sporeless Pleurotus strain of the F2 or F3 generation descending from FiBABH-334 or from a strain derived from FiBABH-334, comprising between 80%-100%, or between 60-80%, or between 40-60%, or between 20-40% of the sequence-characterized allelic markers of FiBABH-334 listed in Table A.

### Claim 9

(canceled)

### Claim 10 (depends on 5)

The sporeless Pleurotus mushroom strain of claim 5, which is a sporeless Pleurotus mushroom strain that is derived from the initial strain FiBABH-334, and comprises at least 85% of the sequence-characterized allelic markers of FiBABH-334 listed in Table A.

### Claim 11 (depends on 1)

A culture of any of the mushroom strain of claim 1, characterized in that:
(a) the total yield performance of the crops of said culture is at least equal to the yield performance of crops of the Spoppo strain of Pleurotus, and
(b) the average total height of the resulting mushrooms, including their stipe and cap, is significantly inferior to the average height of Spoppo mushrooms, and
(c) the average height of the stipes of the resulting mushrooms, is significantly inferior to the average height of Spoppo mushroom stipes, and
(d) the cap of the resulting mushrooms is flatter than the caps of Spoppo mushrooms.

### Claim 12 (depends on 1)

A mushroom produced by growing a crop of mushrooms from the strain of claim 1 any of claim 1.

### Claim 13 (depends on 1)

Cells, spores, hyphae, or mycelium obtained from the strain of claim 1.

### Claim 14

(canceled)

### Claim 15 (depends on 1)

A product incorporating the strain of claim 1, including spawn, inoculum, processed foods, colonised substrates including grain, substrate and friable particulate matter.

### Claim 16 (depends on 1)

A method for producing Pleurotus mushrooms, said method comprising:
a) Inoculating a mushroom growth medium with a sporeless Pleurotus strain of claim 1,
b) Maintaining said inoculated growth medium under conditions conductive to mushroom fruiting and
c) Collecting mushrooms from said growth medium.

### Claim 17

A method for developing a new sporeless Pleurotus culture, said method comprising applying at least one mushroom strain development technique to the strain FiBABH-334, a representative culture of which having been deposited at the Collection Nationale de Cultures de Microorganismes (CNCM), Institut Pasteur, 25 rue du Docteur Roux, 75724 PARIS Cedex 15, on Mar. 21, 2023, under the CNCM Accession Number I-5939, or to a progeny thereof, to provide a new culture.

### Claim 18 (depends on 17)

The method of claim 17, comprising mating a monokaryon of the strain FiBABH-334, a representative culture of said strain having been deposited under the CNCM Accession Number 1-5939 at the Collection Nationale de Cultures de Microorganismes (CNCM), Institut Pasteur, 25 rue du Docteur Roux, 75724 PARIS Cedex 15, on Mar. 21, 2023; or mating a sporeless Pleurotus strain comprising at least one haploid set of chromosomes of the strain FiBABH-334, a representative culture of said strain having been deposited under the CNCM Accession Number 1-5939 at the Collection Nationale de Cultures de Microorganismes (CNCM), Institut Pasteur, 25 rue du Docteur Roux, 75724 PARIS Cedex 15, on Mar. 21, 2023, with a second Pleurotus monokaryon or dikaryon.

### Claim 19 (depends on 5)

A culture of the mushroom strain of claim 5, characterized in that:
(a) the total yield performance of the crops of said culture is at least equal to the yield performance of crops of the Spoppo strain of Pleurotus, and
(b) the average total height of the resulting mushrooms, including their stipe and cap, is significantly inferior to the average height of Spoppo mushrooms, and
(c) the average height of the stipes of the resulting mushrooms, is significantly inferior to the average height of Spoppo mushroom stipes, and
(d) the cap of the resulting mushrooms is flatter than the caps of Spoppo mushrooms.

### Claim 20 (depends on 5)

A mushroom produced by growing a crop of mushrooms from the strain of claim 5.

### Claim 21 (depends on 11)

A mushroom produced by growing a crop of mushrooms from the culture of claim 11.

### Claim 22 (depends on 5)

Cells, spores, hyphae, or mycelium obtained from the strain of claim 5.

### Claim 23 (depends on 11)

Cells, spores, hyphae, or mycelium obtained from the culture of claim 11.

### Claim 24 (depends on 5)

A product incorporating the strain of claim 5, including spawn, inoculum, processed foods, colonised substrates including grain, substrate and friable particulate matter.

### Claim 25 (depends on 11)

A product incorporating the culture of claim 11, including spawn, inoculum, processed foods, colonised substrates including grain, substrate and friable particulate matter.
